Coronary Angiography Devices Market: Technological Advancements in Imaging Drive Cardiac Diagnostic and Therapeutic Procedures

The Coronary Angiography Devices Market is a crucial segment of cardiovascular care, driven by the rising global prevalence of cardiovascular diseases (CVDs) and the corresponding increase in diagnostic and therapeutic angiography procedures. Valued at $11.72 billion in 2023, the market is projected to reach $16.80 billion by 2030 with a CAGR of 6.18%. Coronary angiography is the gold-standard procedure for visualizing the blood vessels of the heart to diagnose blockages or disease. The market includes a wide range of products: angiography systems, catheters, contrast media, and guidewires, with angiography systems being complex imaging setups that allow for real-time visualization using various technologies.

Technological advancements are a primary growth engine. Manufacturers are focused on developing newer imaging systems that offer reduced radiation dosage, improved image quality, and advanced procedural image guidance. Innovations like 3-D imaging with rotational angiography, which creates CT-like anatomical models, are enhancing diagnostic precision. The market is segmented by technology, including X-ray angiography, CT angiography, and MR angiography. Strategic collaborations between imaging technology companies and cardiovascular solution providers—such as the partnership between Canon Medical and Cleerly to integrate AI-powered CT technology for coronary artery disease analysis—are creating a new paradigm for both diagnostics and intervention, ensuring market growth remains robust across developed and fast-growing regions like Asia-Pacific.